Wall St set to open sharply higher on soft jobs data
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
U.S. job growth slows in April
Apple jumps after announcing record share buyback
Expedia slides after trimming FY revenue growth forecast
Futures up: Dow 1.29%, S&P 1.14%, Nasdaq 1.61%
Updated at 8:42 a.m. ET/1242 GMT
By Shristi Achar A and Shashwat Chauhan
May 3 (Reuters) -Wall Street's main indexes were set to open higher on Friday after a softer-than-expected jobs report revived hopes of the Federal Reserve cutting interest rates this year, while gains in Apple and Amgen on upbeat corporate updates added support.
The Labor Department report showed U.S. nonfarm payrolls increased by 175,000 jobs in April, compared with expectations for an increase of 243,000, according to economists polled by Reuters.
The unemployment rate stood at 3.9% compared with expectations that it would remain steady at 3.8%, while average earnings rose 0.2% on a monthly basis against forecasts of 0.3% growth.
"The data is soft across the board from the Fed's perspective, which is what really matters and an unemployment rate of 3.9% is not something disastrous," said Jason Pride, chief of investment strategy and research at Glenmede.
"This indicates an economy that is not declining dramatically, but it definitely indicates a looser labor market."
Money markets are pricing in about 51 basis points of rate cuts from the U.S. central bank this year, compared with about 41 bps prior to the data release, according to LSEG data.
The latest economic data follows the Federal Reserve's more dovish-than-expected interest rate guidance in its latest policy meeting, which caused U.S. stocks to rally on Thursday.
Apple AAPL.O jumped 7.2%, outpacing other megacap stocks in premarket trading on Friday after the iPhone maker unveiled a record $110 billion share buyback program and beat modest expectations for quarterly results and forecast.
Amgen AMGN.O climbed 12.9% as the biotechnology firm said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide and as it reported first-quarter earnings.
Shares of rival Eli Lilly LLY.N dipped 1%, while weight-loss drug developer Viking Therapeutics VKTX.O shed 2.3%.
At 08:42 a.m. ET, Dow E-minis 1YMcv1 were up 497 points, or 1.29%, S&P 500 E-minis EScv1 were up 58.25 points, or 1.14%, and Nasdaq 100 E-minis NQcv1 were up 284 points, or 1.61%.
Block SQ.N rose 9.4% after the Jack Dorsey-led payments fintech firm lifted its full-year adjusted core earnings forecast and revealed plans to add more bitcoins to its balance sheet.
Expedia EXPE.O fell 10.5% after the online travel agency cut its full-year revenue growth forecast as gross bookings were hit by a drag in its vacation rental platform.
Fortinet FTNT.O dipped 7.8% after the cybersecurity firm forecast second-quarter billings below Wall Street estimates.
Reporting by Shristi Achar A and Shashwat Chauhan in Bengaluru, Additional reporting by Ankika Biswas; Editing by Shounak Dasgupta
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
